Editas Medicine, Inc. (NASDAQ:EDIT) Receives $15.00 Consensus PT from Analysts
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target […]
More Stories
Eventide Asset Management LLC Sells 355,699 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
Eventide Asset Management LLC reduced its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 48.1% during the...
Digital Realty Trust, Inc. (NYSE:DLR) Shares Sold by Infrastructure Capital Advisors LLC
Infrastructure Capital Advisors LLC lessened its holdings in shares of Digital Realty Trust, Inc. (NYSE:DLR – Free Report) by 1.2%...
Rockefeller Capital Management L.P. Sells 41,512 Shares of Lowe’s Companies, Inc. (NYSE:LOW)
Rockefeller Capital Management L.P. reduced its stake in Lowe’s Companies, Inc. (NYSE:LOW – Free Report) by 11.5% during the third...
Simon Property Group, Inc. (NYSE:SPG) Position Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Simon Property...
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Broadcom Inc. (NASDAQ:AVGO)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Broadcom Inc. (NASDAQ:AVGO –...
Public Sector Pension Investment Board Makes New Investment in Marvell Technology, Inc. (NASDAQ:MRVL)
Public Sector Pension Investment Board bought a new position in Marvell Technology, Inc. (NASDAQ:MRVL – Free Report) during the 3rd...